Rating History for NewAmsterdam Pharma Co NV (NAMS) by BMO Capital

More Stocks Rated by BMO Capital | Latest Ratings for NAMS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/20/2026 N/A New Coverage Outperform
(N/A)		 58.00
(N/A)		 31.68
(24.92)		 -21.34% Details